| [1] |
Lardelli M, Dahlstrand J, Lendahl U. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factorrepeats and is expressed in proliferating neuroepithelium[J]. Mech Dev,1994,46(2):123-136.
|
| [2] |
Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia[J]. Nature,1996,383(6602):707-710.
|
| [3] |
Bellavia D, Checquolo S, Campese AF, et al. Notch3: from subtle structural differences to functional diversity[J].Oncogene,2008,27(38):5092-5098.
|
| [4] |
Wu F,Stutzman A, Mo YY. Notch signaling and its role in breast cancer[J]. Front Biosci,2007,12(1):4370-4383.
|
| [5] |
Beatus P, Lundkvist J,Oberg C,et al. The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity[J]. Mech Dev,2001,104(1/2):3-20.
|
| [6] |
Bellavia D, Campese AF, Alesse E, et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice[J]. EMBO J,2000,19(13):3337-3348.
|
| [7] |
Bellavia D, Campese AF, Checquolo S, et al. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis[J]. Proc Natl Acad Sci USA,2002,99(6):3788-3793.
|
| [8] |
Indraccolo S, Minuzzo S, Masiero M, et al. Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy[J]. Cancer Res,2009,69(4):1314-1323.
|
| [9] |
Gramantieri L, Giovannini C, Lanzi A, et al. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma[J]. Liver Int,2007,27(7):997-1007.
|
| [10] |
Serafin V, Persano L, Moserle L, et al. Notch3 signalling promotes tumour growth in colorectal cancer[J]. J Pathol,2011,224(4):448-460.
|
| [11] |
Yeasmin S, Nakayama K, Rahman MT, et al. Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes[J]. Gynecol Oncol,2010,117(3):409-416.
|
| [12] |
Park JT, Li M, Nakayama K, et al. Notch3 gene amplification in ovarian cancer[J]. Cancer Res, 2006, 66(12):6312-6318.
|
| [13] |
Park JT, Chen X, Trope CG, et al. Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin[J]. Am J Pathol,2010,177(3):1087-1094.
|
| [14] |
Hu C, Dievart A, Lupien M, et al. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors[J]. Am J Pathol,2006,168(3):973-990.
|
| [15] |
Raafat A, Goldhar AS, Klauzinska M, et al. Expression of Notch receptors, ligands, and target genes during development of the mouse mammary gland[J]. J Cell Physiol,2011,226(7):1940-1952.
|
| [16] |
Chen Y, Fischer WH,Gill GN. Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH[J]. J Biol Chem,1997,272(22):14110-14114.
|
| [17] |
Pradeep CR, Köstler WJ, Lauriola M, et al. Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling[J]. Oncogene,2012,31(7):907-917.
|
| [18] |
Yamaguchi N,Oyama T, Ito E, et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells[J]. Cancer Res,2008,68(6):1881-1888.
|
| [19] |
Hirose H, Ishii H,Mimori K, et al. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors[J]. Oncol Rep,2010,23(1):35-43.
|
| [20] |
Rizzo P, Miao H,D’Souza G, et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches[J]. Cancer Res,2008,68(13):5226-5235.
|
| [21] |
Konishi J, Kawaguchi KS, Vo H, et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers[J]. Cancer Res,2007,67(17):8051-8057.
|
| [22] |
Chen X,Stoeck A, Lee SJ, et al. Jagged1 expression regulated by Notch3 and Wnt/beta-catenin signaling pathways in ovarian cancer[J]. Oncotarget,2010,1(3):210-218.
|